FDA Approves First Interchangeable Biosimilar for Two Rare Diseases

SILVER SPRING, Md., May 28, 2024 /PRNewswire/ — Today, the U.S. Food and Drug Administration approved Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to Soliris (eculizumab) to treat certain rare diseases. Bkemv is approved for the following treatment indications, which…